These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33130461)

  • 21. Large-scale generation of human iPSC-derived neural stem cells/early neural progenitor cells and their neuronal differentiation.
    D'Aiuto L; Zhi Y; Kumar Das D; Wilcox MR; Johnson JW; McClain L; MacDonald ML; Di Maio R; Schurdak ME; Piazza P; Viggiano L; Sweet R; Kinchington PR; Bhattacharjee AG; Yolken R; Nimgaonkar VL
    Organogenesis; 2014; 10(4):365-77. PubMed ID: 25629202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural stem cell therapy-Brief review.
    Grochowski C; Radzikowska E; Maciejewski R
    Clin Neurol Neurosurg; 2018 Oct; 173():8-14. PubMed ID: 30053745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-based therapeutic strategies for multiple sclerosis.
    Scolding NJ; Pasquini M; Reingold SC; Cohen JA; ; ;
    Brain; 2017 Nov; 140(11):2776-2796. PubMed ID: 29053779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.
    López-Serrano C; Torres-Espín A; Hernández J; Alvarez-Palomo AB; Requena J; Gasull X; Edel MJ; Navarro X
    Cell Transplant; 2016 Oct; 25(10):1833-1852. PubMed ID: 27075820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem Cell Therapy for Multiple Sclerosis.
    Genc B; Bozan HR; Genc S; Genc K
    Adv Exp Med Biol; 2019; 1084():145-174. PubMed ID: 30039439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegeneration.
    Orack JC; Deleidi M; Pitt D; Mahajan K; Nicholas JA; Boster AL; Racke MK; Comabella M; Watanabe F; Imitola J
    Stem Cells Transl Med; 2015 Mar; 4(3):252-60. PubMed ID: 25593207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derivation of primitive neural stem cells from human-induced pluripotent stem cells.
    Shin WJ; Seo JH; Choi HW; Hong YJ; Lee WJ; Chae JI; Kim SJ; Lee JW; Hong K; Song H; Park C; Do JT
    J Comp Neurol; 2019 Dec; 527(18):3023-3033. PubMed ID: 31173371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology.
    Bohl D; Pochet R; Mitrecic D; Nicaise C
    Curr Stem Cell Res Ther; 2016; 11(4):301-12. PubMed ID: 26018231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial.
    Brain Res; 2016 May; 1638(Pt A):1. PubMed ID: 27087162
    [No Abstract]   [Full Text] [Related]  

  • 31. Making it personal: the prospects for autologous pluripotent stem cell-derived therapies.
    Blair NF; Barker RA
    Regen Med; 2016 Jul; 11(5):423-5. PubMed ID: 27346669
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell-based reparative therapies for multiple sclerosis.
    Ben-Hur T; Fainstein N; Nishri Y
    Curr Neurol Neurosci Rep; 2013 Nov; 13(11):397. PubMed ID: 24078453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optochemogenetic Stimulation of Transplanted iPS-NPCs Enhances Neuronal Repair and Functional Recovery after Ischemic Stroke.
    Yu SP; Tung JK; Wei ZZ; Chen D; Berglund K; Zhong W; Zhang JY; Gu X; Song M; Gross RE; Lin SZ; Wei L
    J Neurosci; 2019 Aug; 39(33):6571-6594. PubMed ID: 31263065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced neural stem cells (iNSCs) in neurodegenerative diseases.
    Hermann A; Storch A
    J Neural Transm (Vienna); 2013 Sep; 120 Suppl 1():S19-25. PubMed ID: 23720190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
    Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
    Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell and progenitor cell transplantation in multiple sclerosis: the discrepancy between neurobiological attraction and clinical feasibility.
    Lassmann H
    J Neurol Sci; 2005 Jun; 233(1-2):83-6. PubMed ID: 15949497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The stem cells and a problem of regeneration of peripheral nerves].
    Diel'tsova OI; Herashchenko SB; Chaĭkovskyĭ IuB
    Klin Khir; 2013 Jul; (7):65-8. PubMed ID: 24283050
    [No Abstract]   [Full Text] [Related]  

  • 38. Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors.
    Ji B; Kaneko H; Minamimoto T; Inoue H; Takeuchi H; Kumata K; Zhang MR; Aoki I; Seki C; Ono M; Tokunaga M; Tsukamoto S; Tanabe K; Shin RM; Minamihisamatsu T; Kito S; Richmond BJ; Suhara T; Higuchi M
    J Neurosci; 2016 Nov; 36(45):11544-11558. PubMed ID: 27911758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospects and challenges for the use of stem cell technologies to develop novel therapies for Parkinson disease.
    Chinta SJ; Andersen JK
    Cell Cycle; 2011 Dec; 10(24):4179-80. PubMed ID: 22157187
    [No Abstract]   [Full Text] [Related]  

  • 40. An Integrated Miniature Bioprocessing for Personalized Human Induced Pluripotent Stem Cell Expansion and Differentiation into Neural Stem Cells.
    Lin H; Li Q; Lei Y
    Sci Rep; 2017 Jan; 7():40191. PubMed ID: 28057917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.